LivaNova To Buy TandemLife For Up to $250m, Adding Complementary Cardiac Surgery

London-based cardiac surgery and neuroscience group LivaNova PLC is buying privately held Pittsburgh-based TandemLife in a deal worth up to $250m. TandemLife develops advanced cardiopulmonary temporary support systems that are complementary to LivaNova's cardiac surgery segments.

London-based cardiac surgery and neuroscience group LivaNova PLC announced today it inked a deal to buy Pittsburgh-based TandemLife, which develops advanced cardiopulmonary temporary support systems.

LivaNova CEO Damien McDonald said he sees rising use of TandemLife's ExtraCorporeal Life Support (ECLS) and Percutaneous Mechanical Circulatory Support (pMCS) systems, adding that their technological advancements have made these...

More from Deals

More from Business